The European Cancer Congress (ECC) is the largest European platform for presenting the very latest in oncology data to a global audience.

Data from 138 abstracts related to Roche medicines, across 15 cancer types, will be presented at the congress in 2015 – including late-breaking abstracts on data from three investigational medicines across specific types of lung, bladder and skin cancer. The data to be presented demonstrate the significant progress Roche’s pipeline is making in the fields of cancer immunotherapy and targeted medicines.

Beyond our data, find out more about our latest progress in oncology: